Spector, David MD (UIA Investigator)

Clinical research site in Moline, Illinois

Spector, David MD (UIA Investigator) is a clinical research site in Moline, Illinois that hosts paid clinical trials. Active studies at this site cover conditions such as Plasma Cell Myeloma, Estrogen Receptor Negative and HER2/Neu Negative. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 27, 2026.

New trial at Spector, David MD (UIA Investigator)? We'll email you when one opens.

No actively recruiting trials right now

Spector, David MD (UIA Investigator) has no clinical trials currently recruiting participants in our latest ClinicalTrials.gov sync. Nearby research sites in Moline below may have open studies, or browse all Moline clinical trials.

Recent clinical trials at Spector, David MD (UIA Investigator)

These studies are no longer enrolling — shown as a record of the research conducted at this site.

Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

for Plasma Cell Myeloma

909 locations incl. Anchorage

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All·Age: 18+

Code: NCT01863550·Phase 3·Active Not Recruiting·Listed May 2013

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

for Estrogen Receptor Negative

1023 locations incl. Mobile

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All·Age: 18+

Code: NCT02445391·Phase 3·Active Not Recruiting·Listed May 2015

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

for Breast Cancer

1455 locations incl. Birmingham

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT01674140·Phase 3·Active Not Recruiting·Listed Aug 2012

Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

for Recurrent Lung Non-Small Cell Carcinoma

356 locations incl. Scottsdale

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT01708954·Phase 2·Active Not Recruiting·Listed Oct 2012

Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

for Breast Adenocarcinoma

840 locations incl. Anniston

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT00433511·Phase 3·Active Not Recruiting·Listed Feb 2007

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

for Neck Squamous Cell Carcinoma of Unknown Primary

777 locations incl. Mobile

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT00588770·Phase 3·Active Not Recruiting·Listed Jan 2008

Get new-trial alerts for Spector, David MD (UIA Investigator)

We'll email you whenever a new clinical trial starts recruiting at this research site in Moline, IL. Unsubscribe anytime.

More research sites in Moline

Trinity Medical Center (11 trials)
Cardiovascular Medicine (1 trial)
GSK Investigational Site (1 trial)
Mid Valley Research Inc. (1 trial)
MidValley Research, Inc (1 trial)
Quad City Ambulatory Surgery Center (1 trial)
Rock Valley Physical Therapy (1 trial)

Is this your research site?

This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.

Explore more

Paid clinical trials in Moline, IL · Illinois clinical trials